Literature DB >> 11848208

Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone.

Toshifusa Shu1, Hideshi Suzuki, Kenji Hironaka, Kunio Ito.   

Abstract

We attempted the development of rapid oral disintegration tablets by direct compression using co-ground mixture of D-mannitol and crospovidone. The co-ground mixture was prepared with a vibration rod mill. The tablets were formed by compression using a single punch-tableting machine after addition of the co-ground mixture to non-ground D-mannitol, crospovidone and magnesium stearate. Regarding the properties of tablets, hardness and the time of disintegration were measured. The particle diameter and specific surface area of the co-ground mixture were measured. The tablets manufactured from a physical mixture of 30% (w/w) co-ground mixture of D-mannitol and crospovidone (mixed ratio 9 :1) with 65.5% (w/w) of non-ground mannitol, 4% (w/w) of crospovidone, and 0.5% (w/w) of magnesium stearate had good properties for rapidly disintegrating tablets in the oral cavity. They showed the hardness of 4.9 kg and disintegration time of 33 s. We found that adding co-ground mixture of D-mannitol and crospovidone is useful in enhancing hardness of the tablets that could not be achieved by addition of their individually ground mixture. The improvement in the hardness of the tablets was also observed when other saccharides and disintegrants were used. This method was proved to be applicable in the manufacture of tables of ascorbic acid, a water-soluble drug and nifedipine, a slightly water soluble drug; and the dissolution rate of nifedipine from the tablets in water was remarkably improved. The particle sizes of D-mannitol in the co-ground mixture were smaller than that of the individually ground mixture, resulting in a larger specific surface area of the co-ground mixture than that of the individually ground mixture. Therefore, it was presumed that crospovidone acted as a grinding assistant for D-mannitol in the co-grinding process, enhancing the hardness of tablets by increasing the contact area among powder particles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848208     DOI: 10.1248/cpb.50.193

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  7 in total

1.  Design of rapidly disintegrating oral tablets using acid-treated yeast cell wall: a technical note.

Authors:  Tetsuya Ozeki; Yuriko Yasuzawa; Hideyo Katsuyama; Yuuki Takashima; Takahide Kasai; Takahiro Eguchi; Hisaya Kakiuchi; Hiroshi Yuasa; Hiroaki Okada
Journal:  AAPS PharmSciTech       Date:  2003-12-31       Impact factor: 3.246

2.  Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin.

Authors:  Vijay Sharma; Anil K Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2008-01-15       Impact factor: 3.246

3.  Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.

Authors:  Parind Mahendrakumar Desai; Patrick Xuan Hua Er; Celine Valeria Liew; Paul Wan Sia Heng
Journal:  AAPS PharmSciTech       Date:  2014-05-22       Impact factor: 3.246

4.  Formulation and characterization of patient-friendly dosage form of ondansetron hydrochloride.

Authors:  Pk Bhoyar; Dm Biyani; Mj Umekar
Journal:  J Young Pharm       Date:  2010-07

5.  Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.

Authors:  Punit P Shah; Rajashree C Mashru
Journal:  AAPS PharmSciTech       Date:  2008-03-20       Impact factor: 3.246

6.  Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.

Authors:  Shagufta Khan; Prashant Kataria; Premchand Nakhat; Pramod Yeole
Journal:  AAPS PharmSciTech       Date:  2007-06-22       Impact factor: 3.246

7.  Formulation and optimization of fast dissolving intraoral drug delivery system for clobazam using response surface methodology.

Authors:  Rajni Bala; Sushil Khanna; Pravin K Pawar
Journal:  J Adv Pharm Technol Res       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.